Abstract
As a consequence of its central role in the regulation of calcium metabolism in the platelet, the plasma membrane Ca2+-ATPase (PMCA) was assessed for cAMP-dependent and tyrosine phosphorylation. Addition of forskolin or prostaglandin E1, agents known to elevate platelet cAMP and calcium efflux, to platelets pre-labeled with [32P]PO4 resulted in the direct phosphorylation of platelet PMCA. Similarly, addition of the catalytic subunit of protein kinase A to platelet plasma membranes resulted in a 1.4-fold stimulation of activity. Thus, the previously reported inhibition of platelet activation by elevated intracellular cAMP may be accomplished in part by stimulation of PMCA, likely resulting in a decrease in intracellular calcium. Treatment with thrombin evoked tyrosine phosphorylation of platelet PMCA, while PMCA from resting platelets exhibited little tyrosine phosphorylation. Phosphorylation of platelet plasma membranes by pp60(src) resulted in 75% inhibition of PMCA activity within 15 min. Similarly, membranes isolated from thrombin-treated platelets exhibited 40% lower PMCA activity than those from resting platelets. Phosphorylation of erythrocyte ghosts and purified PMCA by pp60(src) also resulted in up to 75% inhibition of Ca2+-ATPase activity, and inhibition was correlated with tyrosine phosphorylation. Sequencing of a peptide obtained after 32P labeling of purified erythrocyte PMCA in vitro showed that tyrosine 1176 of PMCA4b is phosphorylated by pp60(src). These results indicate that tyrosine phosphorylation of platelet PMCA may serve as positive feedback to inhibit PMCA and increase intracellular calcium during platelet activation.
Highlights
Treatment with thrombin evoked tyrosine phosphorylation of platelet plasma membrane Ca2؉-ATPase (PMCA), while PMCA from resting platelets exhibited little tyrosine phosphorylation
These results indicate that tyrosine phosphorylation of platelet PMCA may serve as positive feedback to inhibit PMCA and increase intracellular calcium during platelet activation
Neyses et al [18] demonstrated that both sarcolemmal and erythrocyte PMCAs are phosphorylated by cAMP-dependent kinase resulting in stimulation of Ca2ϩATPase activity
Summary
Materials—Outdated human platelet concentrates and whole blood were obtained from the Louisville Chapter of the American Red Cross and from the Central Kentucky Blood Center (Lexington, KY). Polyclonal antibodies against human erythrocyte PMCA were raised in rabbits as described previously [10], and monoclonal anti-PMCA antibody 5F10 [11] was obtained from Affinity BioReagents (Neshanic Station, NJ). Isoform-specific anti-PMCA antibodies [9] were kindly provided by Dr Ernesto Carafoli (Swiss Federal Institute of Technology, Zurich, Switzerland). Mouse monoclonal anti-phosphotyrosine (PY-20) was purchased from Transduction Laboratories (Lexington, KY). Electrophoresis and Western blotting reagents were obtained from Bio-Rad. Thrombin, prostaglandin E1, ATP, phosphoenolpyruvate, NADH, pyruvate kinase, lactate dehydrogenase, catalytic subunit of cAMP-dependent kinase, and egg yolk phosphatidylcholine were purchased from Sigma. 32P-Labeled Na3PO4 and ATP were products from DuPont NEN.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
